MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 3 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,856,373 | +6.7% | 55,898 | +1.3% | 0.05% | -7.0% |
Q3 2022 | $1,739,000 | +42.5% | 55,166 | +37.5% | 0.06% | +62.9% |
Q2 2022 | $1,220,000 | +4.2% | 40,118 | -11.1% | 0.04% | +52.2% |
Q1 2022 | $1,171,000 | +16.1% | 45,122 | -0.8% | 0.02% | -28.1% |
Q2 2021 | $1,009,000 | -6.7% | 45,503 | +10.5% | 0.03% | -20.0% |
Q1 2021 | $1,081,000 | +112.8% | 41,173 | +51.5% | 0.04% | +66.7% |
Q4 2020 | $508,000 | +22.1% | 27,181 | +10.8% | 0.02% | 0.0% |
Q3 2020 | $416,000 | -39.9% | 24,523 | -17.5% | 0.02% | -79.1% |
Q2 2020 | $692,000 | – | 29,719 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |